BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, Guo W, Zhang C, Chen F, Tan HY, Li S, Wang N, Feng Y. Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. Front Pharmacol 2020;11:601. [PMID: 32477116 DOI: 10.3389/fphar.2020.00601] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuri G, Sanhueza S, Paredes A, Morales G, Cifuentes M, Ormazabal P. Deleterious liver-adipose crosstalk in obesity: Hydroethanolic extract of Lampaya medicinalis Phil. (Verbenaceae) counteracts fatty acid-induced fibrotic marker expression in human hepatocytes. Mol Cell Endocrinol 2023;564:111882. [PMID: 36736687 DOI: 10.1016/j.mce.2023.111882] [Reference Citation Analysis]
2 Park HB, Kim SJ, Yadav D, An EK, Zhang W, Eom HY, Kwak M, Oda T, Lee PC, Jin JO. Pyropia yezoensis-derived porphyran attenuates acute and chronic colitis by suppressing dendritic cells. Int J Biol Macromol 2023;231:123148. [PMID: 36639074 DOI: 10.1016/j.ijbiomac.2023.123148] [Reference Citation Analysis]
3 Xu Y, Chen J, Shi S, Gao W, Wu J, Gong H, Zhao Y, Chen W, Wang H, Wang S. Structure characterization of pectin from the pollen of Typha angustifolia L. and the inhibition activity of lipid accumulation in oleic acid induced L02 cells. Carbohydr Polym 2023;303:120452. [PMID: 36657842 DOI: 10.1016/j.carbpol.2022.120452] [Reference Citation Analysis]
4 Grzych G, Bernard L, Lestrelin R, Tailleux A, Staels B. [State of the art on the pathophysiology, diagnosis and treatment of non-alcoholic steatohepatitis (NASH)]. Ann Pharm Fr 2023;81:183-201. [PMID: 36126753 DOI: 10.1016/j.pharma.2022.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li Z, Cao S, Zhao S, Kang N. A bibliometric analysis and visualization of nonalcoholic fatty liver disease from 2012 to 2021. Clin Exp Med 2023. [PMID: 36795238 DOI: 10.1007/s10238-023-01023-2] [Reference Citation Analysis]
6 Mardi P, Kargar R, Fazeli R, Qorbani M. Allium sativum: A potential natural compound for NAFLD prevention and treatment. Front Nutr 2023;10:1059106. [PMID: 36819702 DOI: 10.3389/fnut.2023.1059106] [Reference Citation Analysis]
7 Foghis M, Bungau SG, Bungau AF, Vesa CM, Purza AL, Tarce AG, Tit DM, Pallag A, Behl T, Ul Hassan SS, Radu AF. Plants-based medicine implication in the evolution of chronic liver diseases. Biomed Pharmacother 2023;158:114207. [PMID: 36916432 DOI: 10.1016/j.biopha.2022.114207] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pipitone RM, Zito R, Lupo G, Javed A, La Mantia C, Di Maria G, Pratelli G, Di Salvo F, Fontana S, Pucci M, Carlisi D, Grimaudo S. Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line. Molecules 2023;28. [PMID: 36770927 DOI: 10.3390/molecules28031261] [Reference Citation Analysis]
9 Xiao Y, Xiao L, Li M, Liu S, Wang Y, Huang L, Liu S, Jiang T, Zhou L, Li Y. Perillartine protects against metabolic associated fatty liver in high-fat diet-induced obese mice. Food Funct 2023;14:961-77. [PMID: 36541423 DOI: 10.1039/d2fo02227c] [Reference Citation Analysis]
10 Alshehade SA, Al Zarzour RH, Mathai M, Giribabu N, Seyedan A, Kaur G, Al-Suede FSR, Majid AMSA, Murugaiyah V, Almoustafa H, Alshawsh MA. Orthosiphon aristatus (Blume) Miq Alleviates Non-Alcoholic Fatty Liver Disease via Antioxidant Activities in C57BL/6 Obese Mice and Palmitic-Oleic Acid-Induced Steatosis in HepG2 Cells. Pharmaceuticals (Basel) 2023;16. [PMID: 36678606 DOI: 10.3390/ph16010109] [Reference Citation Analysis]
11 Xu J, Zhang J, Lin H, Zhang J, Zhou R, Wu X, Niu Y, Zhang J. Preparation of oral nanoparticles of Perillae Fructus oil and prevention application of cold stress in mice. Food Science & Nutrition 2022. [DOI: 10.1002/fsn3.3202] [Reference Citation Analysis]
12 Xueru Chu, Yu Zhou, Shuimi Zhang, Shousheng Liu, Guoyun Li, Yongning Xin. Chaetomorpha linum polysaccharides alleviate NAFLD in mice by enhancing the PPARα/CPT-1/MCAD signaling. Lipids Health Dis 2022;21:140. [PMID: 36529726 DOI: 10.1186/s12944-022-01730-x] [Reference Citation Analysis]
13 Jiang H, Mao T, Sun Z, Shi L, Han X, Zhang Y, Zhang X, Wang J, Hu J, Zhang L, Li J, Han H. Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota. Front Microbiol 2022;13:1001778. [PMID: 36578580 DOI: 10.3389/fmicb.2022.1001778] [Reference Citation Analysis]
14 Ning DS, Chen YJ, Lin CJ, Wang CC, Zhao HW, Wang KT, Lee MC, Tayo LL, Chiu WC, Yeh CL, Lee CJ. Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidation. Front Pharmacol 2022;13:1026912. [PMID: 36506588 DOI: 10.3389/fphar.2022.1026912] [Reference Citation Analysis]
15 Deng A, Liu F, Tang X, Wang Y, Xie P, Yang Q, Xiao B. Water extract from artichoke ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats. BMC Complement Med Ther 2022;22:308. [PMID: 36424606 DOI: 10.1186/s12906-022-03794-9] [Reference Citation Analysis]
16 Khan S, Ibrahim M. A systematic review on hepatoprotective potential of grape and polyphenolic compounds: molecular mechanism and future prospective. NRFHH 2022;3:196-213. [DOI: 10.53365/nrfhh/156261] [Reference Citation Analysis]
17 Park MN, Rahman MA, Rahman MH, Kim JW, Choi M, Kim JW, Choi J, Moon M, Ahmed KR, Kim B. Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases. Antioxidants 2022;11:2041. [DOI: 10.3390/antiox11102041] [Reference Citation Analysis]
18 Wang H, Li Y, Bian Y, Li X, Wang Y, Wu K, Liu C, Liu Y, Wang X. Potential hepatoprotective effects of Cistanche deserticola Y.C. Ma: Integrated phytochemical analysis using UPLC-Q-TOF-MS/MS, target network analysis, and experimental assessment. Front Pharmacol 2022;13:1018572. [DOI: 10.3389/fphar.2022.1018572] [Reference Citation Analysis]
19 Sitthirach C, Charoensuk L, Pairojkul C, Chaidee A, Intuyod K, Pongking T, Thongpon P, Jantawong C, Hongsrichan N, Waraasawapati S, Yingklang M, Pinlaor S. Curcumin-loaded nanocomplexes ameliorate the severity of nonalcoholic steatohepatitis in hamsters infected with Opisthorchis viverrini. PLoS ONE 2022;17:e0275273. [DOI: 10.1371/journal.pone.0275273] [Reference Citation Analysis]
20 Gao R, Zhang X, Zhou Z, Sun J, Tang X, Li J, Zhou X, Shen T. Pharmacological Mechanism of Ganlu Powder in the Treatment of NASH Based on Network Pharmacology and Molecular Docking. Dis Markers 2022;2022:7251450. [PMID: 35811658 DOI: 10.1155/2022/7251450] [Reference Citation Analysis]
21 Jia W, Wang K, Zhang S, Lu W, Du A, Li J, Ji L, Xu H. Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease. Phytomedicine 2022;104:154326. [PMID: 35853303 DOI: 10.1016/j.phymed.2022.154326] [Reference Citation Analysis]
22 Panda AK, Rout S, Biswal AR, Kar S. Prevention and to stop the progression of fatty liver diseases: Evidence of ayurveda in hand. JPMHH 2022;8:9-15. [DOI: 10.18231/j.jpmhh.2022.003] [Reference Citation Analysis]
23 Zhang X, Gao R, Zhou Z, Sun J, Tang X, Li J, Zhou X, Shen T. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation. J Ethnopharmacol 2022;296:115405. [PMID: 35644437 DOI: 10.1016/j.jep.2022.115405] [Reference Citation Analysis]
24 Balkrishna A, Gohel V, Kumari P, Manik M, Bhattacharya K, Dev R, Varshney A. Livogrit Prevents Methionine-Cystine Deficiency Induced Nonalcoholic Steatohepatitis by Modulation of Steatosis and Oxidative Stress in Human Hepatocyte-Derived Spheroid and in Primary Rat Hepatocytes. Bioengineered 2022;13:10811-26. [PMID: 35485140 DOI: 10.1080/21655979.2022.2065789] [Reference Citation Analysis]
25 Alzahrani NS, Alshammari GM, El-Ansary A, Yagoub AEA, Amina M, Saleh A, Yahya MA. Anti-Hyperlipidemia, Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet. Nutrients 2022;14:1791. [PMID: 35565759 DOI: 10.3390/nu14091791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Nwakiban Atchan AP, Shivashankara ST, Piazza S, Tchamgoue AD, Beretta G, Dell'Agli M, Magni P, Agbor GA, Kuiaté JR, Manjappara UV. Polyphenol-Rich Extracts of Xylopia and Aframomum Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation in Diet-Induced Obese Mice. ACS Omega 2022;7:11914-28. [PMID: 35449947 DOI: 10.1021/acsomega.2c00050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Geng Q, Zhang P, Liu X, Xue L. Effect of berberine and bicyclol on Chinese patients with non-alcoholic fatty liver disease: a retrospective study. Postgrad Med 2022. [PMID: 35382695 DOI: 10.1080/00325481.2022.2063568] [Reference Citation Analysis]
28 Ke Y, Chen T, Tang R, Lin J, Lin F. Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD). APL Bioengineering 2022;6:016102. [DOI: 10.1063/5.0081695] [Reference Citation Analysis]
29 Jeon SH, Jang E, Park G, Lee Y, Jang YP, Lee KT, Inn KS, Lee JK, Lee JH. Beneficial Activities of Alisma orientale Extract in a Western Diet-Induced Murine Non-Alcoholic Steatohepatitis and Related Fibrosis Model via Regulation of the Hepatic Adiponectin and Farnesoid X Receptor Pathways. Nutrients 2022;14:695. [PMID: 35277054 DOI: 10.3390/nu14030695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Sabir U, Irfan HM, Alamgeer, Ullah A, Althobaiti YS, Asim MH. Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach. JIR 2022;Volume 15:1293-316. [DOI: 10.2147/jir.s354878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Huang P, Yang L, Liu Y, Jiang Y, Li Y, Chen Z, Song H, Zheng P. Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPARα Signaling Pathway. Evid Based Complement Alternat Med 2022;2022:1124901. [PMID: 35035496 DOI: 10.1155/2022/1124901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Prasoppokakorn T, Pitisuttithum P, Treeprasertsuk S. Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). J Clin Transl Hepatol 2021;9:939-46. [PMID: 34966657 DOI: 10.14218/JCTH.2021.00189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
33 Ma Y, Sun K, Cao J, Qin X, Shi J, Li H, Zhang J, Zhang T. Acupuncture combined with Chinese herbal medicine on non-alcoholic fatty liver disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e28083. [PMID: 34941049 DOI: 10.1097/MD.0000000000028083] [Reference Citation Analysis]
34 Chen M, Gu Y, Huang F, Zhong G, Men L, Liu Q, Luan J, Tong G. Effectiveness and safety of Shugan Jianpi (SGJP) formula in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2021;100:e28366. [PMID: 34941156 DOI: 10.1097/MD.0000000000028366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Song C, Lv W, Li Y, Nie P, Lu J, Geng Y, Heng Z, Song L. Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed rats. Nutr Metab (Lond) 2021;18:106. [PMID: 34922572 DOI: 10.1186/s12986-021-00631-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Shan D, Wang J, Di Q, Jiang Q, Xu Q. Steatosis induced by nonylphenol in HepG2 cells and the intervention effect of curcumin. Food Funct 2021. [PMID: 34904613 DOI: 10.1039/d1fo02481g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Masnadi Shirazi K, Shirinpour E, Masnadi Shirazi A, Nikniaz Z. Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial. BMC Complement Med Ther 2021;21:283. [PMID: 34798892 DOI: 10.1186/s12906-021-03436-6] [Reference Citation Analysis]
38 Li S, Li X, Chen F, Liu M, Ning L, Yan Y, Zhang S, Huang S, Tu C. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction. J Nutr Biochem 2021;100:108888. [PMID: 34695558 DOI: 10.1016/j.jnutbio.2021.108888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
39 Chen M, Xie Y, Gong S, Wang Y, Yu H, Zhou T, Huang F, Guo X, Zhang H, Huang R, Han Z, Xing Y, Liu Q, Tong G, Zhou H. Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis. Pharmacol Res 2021;172:105849. [PMID: 34450307 DOI: 10.1016/j.phrs.2021.105849] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
40 Chen K, Qu J, Chen H, Wang J, Hua H, Li J, Zhou L, Zhang W, Li Z. Investigating the medicinal potential, material basis and mechanism of Polygoni Orientalis Fructus based on multi-technology integrated network pharmacology. Phytomedicine 2021;91:153685. [PMID: 34339945 DOI: 10.1016/j.phymed.2021.153685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 El Seedy GM, El-Shafey ES, Elsherbiny ES. Ziziphus spina-christi (L.) fortified with Camellia sinensis mediates apoptosis, Notch-1 signaling, and mitigates obesity-induced non-alcoholic fatty liver. J Food Biochem 2021;:e13849. [PMID: 34245170 DOI: 10.1111/jfbc.13849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Xu Z, Lin S, Gong J, Feng P, Cao Y, Li Q, Jiang Y, You Y, Tong Y, Wang P. Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation. Front Med (Lausanne) 2021;8:681391. [PMID: 34179049 DOI: 10.3389/fmed.2021.681391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Zaremba Y, Smaliukh O, Zaremba O. Effectiveness of Hepatoprotectors in the Practice of a Family Doctor. FM 2021. [DOI: 10.30841/2307-5112.1.2021.231939] [Reference Citation Analysis]
44 Abou Assi R, Abdulbaqi IM, Siok Yee C. The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. Pharmaceuticals (Basel) 2021;14:215. [PMID: 33806527 DOI: 10.3390/ph14030215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Sandhu N, Au J. Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis. Curr Hepatology Rep 2021;20:1-11. [DOI: 10.1007/s11901-020-00558-2] [Reference Citation Analysis]
46 Shekarchizadeh-Esfahani P, Heydarpour F, Izadi F, Jalili C. The effect of cinnamon supplementation on liver enzymes in adults: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 2021;58:102699. [PMID: 33639251 DOI: 10.1016/j.ctim.2021.102699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Ying Y, Zhang H, Yu D, Zhang W, Zhou D, Liu S. Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis. Evid Based Complement Alternat Med 2021;2021:6659445. [PMID: 33643422 DOI: 10.1155/2021/6659445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sci 2021;271:119220. [PMID: 33592199 DOI: 10.1016/j.lfs.2021.119220] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
49 Liang W, Zhou K, Jian P, Chang Z, Zhang Q, Liu Y, Xiao S, Zhang L. Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis. Front Pharmacol 2021;12:622841. [PMID: 33679403 DOI: 10.3389/fphar.2021.622841] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
50 Liang Z, Chen X, Shi J, Hu H, Xue Y, Ung COL. Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials. Chin Med 2021;16:9. [PMID: 33430929 DOI: 10.1186/s13020-020-00422-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
51 Balkrishna A, Gohel V, Singh R, Joshi M, Varshney Y, Srivastava J, Bhattacharya K, Varshney A. Tri-Herbal Medicine Divya Sarva-Kalp-Kwath (Livogrit) Regulates Fatty Acid-Induced Steatosis in Human HepG2 Cells through Inhibition of Intracellular Triglycerides and Extracellular Glycerol Levels. Molecules 2020;25:E4849. [PMID: 33096687 DOI: 10.3390/molecules25204849] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]